Age, PSA level, Gleason score, tumor stage (T stage and M stage), laterality, and ethnicity were compared between the ETV4-fusion-positive and -negative prostate cancer groups, and no significant difference was observed (Table 1). This evidence concerns the gene ETV4 and prostate carcinoma.